These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38023551)

  • 1. Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study.
    Conway A; Stevens A; Murray C; Prain B; Power C; McNulty A; Carrington N; Lu H; Kingsland M; McGrath C; Read P; Starr M; Catlett B; Cunningham P; Grebely J
    Open Forum Infect Dis; 2023 Nov; 10(11):ofad517. PubMed ID: 38023551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot.
    Carrington N; Conway A; Grebely J; Starr M; Catlett B; Stevens A; Prain B; McGrath C; Causer L; Guy R; Holden J; Keen P; Kingsland M; Lu H; Power C; Read P; Murray C; McNulty A; Cunningham P;
    BMC Infect Dis; 2024 Jan; 24(1):137. PubMed ID: 38287234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Aptima HCV Quant Dx Assay for Hepatitis C Virus RNA Detection from Fingerstick Capillary Dried Blood Spot and Venepuncture-Collected Samples.
    Catlett B; Bajis S; Starr M; Dore GJ; Hajarizadeh B; Cunningham PH; Applegate TL; Grebely J
    J Infect Dis; 2021 Mar; 223(5):818-826. PubMed ID: 32710758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the hepatitis C cascade of care among people living with HIV in New South Wales, Australia: A data linkage study.
    Hosseini-Hooshyar S; Alavi M; Martinello M; Valerio H; Tillakeratne S; Matthews GV; Dore GJ
    J Viral Hepat; 2022 Apr; 29(4):271-279. PubMed ID: 35175671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timely Hepatitis C RNA Testing and Treatment in the Era of Direct-Acting Antiviral Therapy among People with Hepatitis C in New South Wales, Australia.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 'one-stop-shop' point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study.
    Sheehan Y; Cunningham EB; Cochrane A; Byrne M; Brown T; McGrath C; Lafferty L; Tedla N; Dore GJ; Lloyd AR; Grebely J
    J Hepatol; 2023 Sep; 79(3):635-644. PubMed ID: 37116714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.
    Bajis S; Maher L; Treloar C; Hajarizadeh B; Lamoury FMJ; Mowat Y; Schulz M; Marshall AD; Cunningham EB; Cock V; Ezard N; Gorton C; Hayllar J; Smith J; Whelan M; Martinello M; Applegate TL; Dore GJ; Grebely J;
    Int J Drug Policy; 2018 Nov; 61():23-30. PubMed ID: 30388566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Molecular Point-of-Care Testing and Dried Blood Spot for Hepatitis C Virus Screening in People Who Inject Drugs.
    Chevaliez S; Wlassow M; Volant J; Roudot-Thoraval F; Bachelard A; Poiteau L; Trabut JB; Hézode C; Bourdel A; Dominguez S
    Open Forum Infect Dis; 2020 Jun; 7(6):ofaa196. PubMed ID: 32617372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "That was quick, simple, and easy": Patient perceptions of acceptability of point-of-care hepatitis C RNA testing at a reception prison.
    Lafferty L; Cochrane A; Sheehan Y; Treloar C; Grebely J; Lloyd AR
    Int J Drug Policy; 2022 Jan; 99():103456. PubMed ID: 34560624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
    Hajarizadeh B; Grebely J; Byrne M; Marks P; Amin J; McManus H; Butler T; Cunningham EB; Vickerman P; Martin NK; McHutchison JG; Brainard DM; Treloar C; Chambers GM; Grant L; Mcgrath C; Lloyd AR; Dore GJ;
    Lancet Gastroenterol Hepatol; 2021 Jul; 6(7):533-546. PubMed ID: 33965006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots.
    Catlett B; Carrera A; Starr M; Applegate TL; Lowe P; Grebely J; Philip Cunningham H
    J Clin Virol; 2019 Mar; 112():40-44. PubMed ID: 30776575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in hepatitis C antibody prevalence among Aboriginal and Torres Strait Islander people attending Australian Needle and Syringe Programs, 1996-2015.
    Graham S; Maher L; Wand H; Doyle M; Iversen J
    Int J Drug Policy; 2017 Sep; 47():69-76. PubMed ID: 28735774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Automated and combined HIV, HBV, HCV, and syphilis testing among illegal gold miners in French Guiana using a standardized dried blood device.
    Pisoni A; Reynaud E; Douine M; Hureau L; Alcocer Cordellat C; Schaub R; Poland D; Monkel R; Lommen J; Yenkoyan K; Vreden S; Nacher M; Tuaillon E
    Acta Trop; 2023 Feb; 238():106731. PubMed ID: 36395882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of dried blood spots as a feasible alternative to plasma for the detection and quantification of hepatitis c virus in a tropical setting: A pilot study.
    Ranjan J; Ponnuvel S; Fletcher GJ; Anantharam R; Radhakrishnan K; Jeyaseelan V; Abraham P
    Indian J Med Microbiol; 2019; 37(1):60-66. PubMed ID: 31424012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016).
    Lydié N; Saboni L; Gautier A; Brouard C; Chevaliez S; Barin F; Larsen C; Lot F; Rahib D
    JMIR Res Protoc; 2018 Oct; 7(10):e180. PubMed ID: 30314963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of storage time in dried blood samples (DBS) and dried plasma samples (DPS) for point-of-care hepatitis C virus (HCV) RNA quantification and HCV core antigen detection.
    Troyano-Hernáez P; Herrador P; Gea F; Romero-Hernández B; Reina G; Albillos A; Galán JC; Holguín Á
    Microbiol Spectr; 2023 Sep; 11(5):e0174823. PubMed ID: 37655908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory-based testing for hepatitis C infection using dried blood spot samples: A systematic review and meta-analysis of diagnostic accuracy.
    Carty PG; McCarthy M; O'Neill SM; De Gascun CF; Harrington P; O'Neill M; Smith SM; Teljeur C; Ryan M
    Rev Med Virol; 2022 Jul; 32(4):e2320. PubMed ID: 34957630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating utilising the Alinity m platform to detect hepatitis C virus RNA in dried blood spot samples.
    Goldstein EJ; Shepherd SJ; Gunson RN
    J Clin Virol; 2020 Nov; 132():104647. PubMed ID: 32979769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Hepatitis C Among Australian Aboriginal and Torres Strait Islander people: A Systematic Review and Meta-Analysis.
    Graham S; Harrod ME; Iversen J; Simone Hocking J
    Hepat Mon; 2016 Jul; 16(7):e38640. PubMed ID: 27651805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.